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March 7, 2006:1082–90omparison of Bioprostheses
n Patients With Small Aortic Annulus
am writing to comment on the study by Botzenhardt et al. (1) in
recent issue of the Journal.
This interesting report compared different forms of bioprosthe-
es, particularly in the small annular sizes for the aortic root. My
eason for writing is related to the conclusion and the discussion
egarding patients, particularly elderly ones, who need aortic valve
eplacement and who have relatively small annular diameters,
amely 19, 21, or 23 mm. I would disagree with the authors’
onclusions that “especially older women who often present with
arrow left ventricular outflow tracts small aortic annulus and
herefore a surgical procedure in this patient group, according to
ur results properly require root enlargement.” I would like to
mphasize strongly that this is a somewhat hazardous recommen-
ation, particularly in the elderly who have many other comor-
idities and where a prolonged operation could lead to increased
orbidity and even mortality. The researchers quote recommen-
ations by the American College of Cardiology that the surgical
rocedure in this patient group should be a root enlargement. I
trongly suggest that many of us who deal with these very frail
lderly and oftentimes very sick patients would do well to implant
hese newer forms of more hemodynamically efficient bioprosthe-
es, as mentioned in their study, even in the 19-mm range rather
han extensive root enlargements for theoretical hemodynamic
ain.
Increasing numbers of elderly patients (numbering some 50
illion by the year 2015) will require aortic valve replacement. We
ust devise strategies and use the best bioprostheses in this group
o get patients through surgery and improve their hemodynamics,
hile balancing the risk and reward of these procedures.
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EPLY
ur study about four stented bioprostheses implanted in patients
ith a small aortic annulus observed high incidences of patient–
rosthesis mismatch in subjects with an aortic annulus of 18 to 20
m independent of the chosen valve type (1). These patients may
emodynamically benefit from aortic root enlargement and the
mplantation of a larger stented bioprosthesis. However, the
ecision to extend the operative procedure from an isolated aortic
alve replacement to valve replacement plus root enlargement,
hich may lead to increased morbidity and mortality (2), mustlways be integrated in a differentiated and extensive assessment of bhe patient’s comorbidities, age, and lifestyle and must not be
isunderstood as a general recommendation. Prolongation of the
ardiopulmonary bypass time may be especially associated with
ncreased operative and 30-day mortality in patients 80 years of
ge (3).
Thus, we concur with Dr. Cohn that “we must devise strategies
nd use the best bioprostheses in this group to get patients through
urgery and improve their hemodynamics, while balancing the risk
nd reward of these procedures.” We emphasized this concept with
eference to the American Collage of Cardiology/American Heart
ssociation (ACC/AHA) guidelines for the management of
atients with valvular heart disease: “A narrow LV [left ventricu-
ar] outflow tract and a small aortic annulus sometimes present in
lderly women may require enlargement of the annulus. The
ecision to proceed with valve replacement depends on an impre-
ise analysis that considers the balance between the potential for
mproved symptoms and survival and the morbidity and mortality
f surgery” (4). We did not cite these guidelines to support the
idespread use of aortic root enlargement. The operative proce-
ure at our department reflects the integration of investigational
esults in real-world surgery, as “we do not always perform aortic
oot enlargement in case of patient–prosthesis mismatch in this
atient group, setting priority to achieve low rates of perioperative
dverse events. However, we sometimes have to accept suboptimal
emodynamic performance” (1).
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he Morphed Specialist—An Androsphinx?
r. DeMaria in his editorial (1) on the morphing of cardiovascular
pecialists rightly points out that there will be a blurring of the
orders between specialties. Newer technological developments
